166 related articles for article (PubMed ID: 16283096)
1. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.
Koch M; Ramsaransing GS; Arutjunyan AV; Stepanov M; Teelken A; Heersema DJ; De Keyser J
J Neurol; 2006 Apr; 253(4):483-7. PubMed ID: 16283096
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.
Koch M; Mostert J; Arutjunyan A; Stepanov M; Teelken A; Heersema D; De Keyser J
Mult Scler; 2008 Mar; 14(2):159-65. PubMed ID: 17942516
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course.
Ramsaransing GS; Teelken A; Arutjunyan AV; De Keyser J
Neurology; 2004 Jan; 62(2):239-42. PubMed ID: 14745060
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
5. Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Guan JZ; Guan WP; Maeda T; Guoqing X; GuangZhi W; Makino N
Mol Cell Biochem; 2015 Feb; 400(1-2):183-7. PubMed ID: 25424527
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis.
Ramsaransing GS; Heersema DJ; De Keyser J
Eur J Neurol; 2005 Jul; 12(7):514-8. PubMed ID: 15958090
[TBL] [Abstract][Full Text] [Related]
8. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients.
Ferretti G; Bacchetti T; DiLudovico F; Viti B; Angeleri VA; Danni M; Provinciali L
Neurochem Int; 2006 Jan; 48(2):87-92. PubMed ID: 16263194
[TBL] [Abstract][Full Text] [Related]
9. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses.
Mostert JP; Ramsaransing GS; Heersema DJ; Heerings M; Wilczak N; De Keyser J
J Neurol Sci; 2005 Apr; 231(1-2):41-4. PubMed ID: 15792819
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipid peroxidation and progression of disability in multiple sclerosis.
Koch M; Mostert J; Arutjunyan AV; Stepanov M; Teelken A; Heersema D; De Keyser J
Eur J Neurol; 2007 May; 14(5):529-33. PubMed ID: 17437612
[TBL] [Abstract][Full Text] [Related]
12. Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Braidy N; Lim CK; Grant R; Brew BJ; Guillemin GJ
Brain Res; 2013 Nov; 1537():267-72. PubMed ID: 23973746
[TBL] [Abstract][Full Text] [Related]
13. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics.
Pasquali L; Pecori C; Lucchesi C; LoGerfo A; Iudice A; Siciliano G; Bonuccelli U
Clin Biochem; 2015 Jan; 48(1-2):19-23. PubMed ID: 25300461
[TBL] [Abstract][Full Text] [Related]
14. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
[TBL] [Abstract][Full Text] [Related]
15. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
16. Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis.
Ferreira KPZ; Oliveira SR; Kallaur AP; Kaimen-Maciel DR; Lozovoy MAB; de Almeida ERD; Morimoto HK; Mezzaroba L; Dichi I; Reiche EMV; Simão ANC
J Neurol Sci; 2017 Feb; 373():236-241. PubMed ID: 28131195
[TBL] [Abstract][Full Text] [Related]
17. Serum NSE level and disability progression in multiple sclerosis.
Koch MW; George S; Wall W; Wee Yong V; Metz LM
J Neurol Sci; 2015 Mar; 350(1-2):46-50. PubMed ID: 25686504
[TBL] [Abstract][Full Text] [Related]
18. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis.
Miller E; Mrowicka M; Saluk-Juszczak J; Ireneusz M
Neurochem Res; 2011 Jun; 36(6):1012-6. PubMed ID: 21399906
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in ischaemic stroke.
Nanetti L; Raffaelli F; Vignini A; Perozzi C; Silvestrini M; Bartolini M; Provinciali L; Mazzanti L
Eur J Clin Invest; 2011 Dec; 41(12):1318-22. PubMed ID: 21623777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
